Academic Journal
Meningioma classification by immunohistochemistry: A replicability study
Title: | Meningioma classification by immunohistochemistry: A replicability study |
---|---|
Authors: | Olivia Näslund, Anna Lipatnikova, Anna Dénes, Cecilia Lindskog, Thomas Olsson Bontell, Anja Smits, Asgeir S. Jakola, Alba Corell |
Source: | Brain and Spine, Vol 3, Iss , Pp 101711- (2023) |
Publisher Information: | Elsevier, 2023. |
Publication Year: | 2023 |
Collection: | LCC:Neurology. Diseases of the nervous system |
Subject Terms: | Meningioma, Molecular marker, Recurrence, Immunohistochemistry, Neurology. Diseases of the nervous system, RC346-429 |
More Details: | Introduction: Meningiomas account for nearly 40% of intracranial tumors. Recently, the immunohistochemistry (IHC) markers S100B, SCGN, ACADL and MCM2 have been shown to be associated with underlying biological subtypes of meningioma (MG1-MG4). We aimed to evaluate these IHC markers in a clinical setting. Research question: Are the new proposed IHC markers clinically useful? Methods: In total, 244 patients with meningiomas with tissue in TMAs were included and the IHC markers S100B, SCGN, ACADL and MCM2 were analyzed. Two sets of analyses were performed; the first included all samples with any staining considered positive, the second only samples with >10% immunopositivity. PFS and OS were analyzed in correlation to immunopositivity in the second analysis set. Results: In the first set of analyses only 26.2% of samples could be to allocate to one group. No further analyses were performed with this selection. In the second set of analyses 52.0% could be allocated to a group. There was an enrichment of WHO grade 2 and 3 tumors in MG3 and MG4 as compared to MG1 (24.1% and 25.7% vs. 12.1%). Both the molecular group (p = 0.032) and WHO grade (p = 0.005) had significant impact on PFS, but only WHO grade predicted OS (p = 0.033). Conclusion: We studied the proposed new method of classifying meningiomas into groups MG1, MG2, MG3 and MG4 using IHC markers, but found difficulties applying the classification system in our material mainly due to lack of exclusivity of markers. Thus, in its present form the classification method lacks clinical applicability. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 2772-5294 |
Relation: | http://www.sciencedirect.com/science/article/pii/S2772529422008529; https://doaj.org/toc/2772-5294 |
DOI: | 10.1016/j.bas.2022.101711 |
Access URL: | https://doaj.org/article/3526948f62164cc3891252fd2ef9d639 |
Accession Number: | edsdoj.3526948f62164cc3891252fd2ef9d639 |
Database: | Directory of Open Access Journals |
FullText | Links: – Type: other Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=45609329AD21F2A66494&Show=Object Text: Availability: 0 CustomLinks: – Url: https://www.doi.org/10.1016/j.bas.2022.101711? Name: ScienceDirect (all content)-s8985755 Category: fullText Text: View record from ScienceDirect MouseOverText: View record from ScienceDirect – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=27725294&ISBN=&volume=3&issue=101711-&date=20230101&spage=&pages=&title=Brain and Spine&atitle=Meningioma%20classification%20by%20immunohistochemistry%3A%20A%20replicability%20study&aulast=Olivia%20N%C3%A4slund&id=DOI:10.1016/j.bas.2022.101711 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries – Url: https://doaj.org/article/3526948f62164cc3891252fd2ef9d639 Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from DOAJ MouseOverText: View record from DOAJ |
---|---|
Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.3526948f62164cc3891252fd2ef9d639 RelevancyScore: 955 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 954.677185058594 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Meningioma classification by immunohistochemistry: A replicability study – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Olivia+Näslund%22">Olivia Näslund</searchLink><br /><searchLink fieldCode="AR" term="%22Anna+Lipatnikova%22">Anna Lipatnikova</searchLink><br /><searchLink fieldCode="AR" term="%22Anna+Dénes%22">Anna Dénes</searchLink><br /><searchLink fieldCode="AR" term="%22Cecilia+Lindskog%22">Cecilia Lindskog</searchLink><br /><searchLink fieldCode="AR" term="%22Thomas+Olsson+Bontell%22">Thomas Olsson Bontell</searchLink><br /><searchLink fieldCode="AR" term="%22Anja+Smits%22">Anja Smits</searchLink><br /><searchLink fieldCode="AR" term="%22Asgeir+S%2E+Jakola%22">Asgeir S. Jakola</searchLink><br /><searchLink fieldCode="AR" term="%22Alba+Corell%22">Alba Corell</searchLink> – Name: TitleSource Label: Source Group: Src Data: Brain and Spine, Vol 3, Iss , Pp 101711- (2023) – Name: Publisher Label: Publisher Information Group: PubInfo Data: Elsevier, 2023. – Name: DatePubCY Label: Publication Year Group: Date Data: 2023 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Neurology. Diseases of the nervous system – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Meningioma%22">Meningioma</searchLink><br /><searchLink fieldCode="DE" term="%22Molecular+marker%22">Molecular marker</searchLink><br /><searchLink fieldCode="DE" term="%22Recurrence%22">Recurrence</searchLink><br /><searchLink fieldCode="DE" term="%22Immunohistochemistry%22">Immunohistochemistry</searchLink><br /><searchLink fieldCode="DE" term="%22Neurology%2E+Diseases+of+the+nervous+system%22">Neurology. Diseases of the nervous system</searchLink><br /><searchLink fieldCode="DE" term="%22RC346-429%22">RC346-429</searchLink> – Name: Abstract Label: Description Group: Ab Data: Introduction: Meningiomas account for nearly 40% of intracranial tumors. Recently, the immunohistochemistry (IHC) markers S100B, SCGN, ACADL and MCM2 have been shown to be associated with underlying biological subtypes of meningioma (MG1-MG4). We aimed to evaluate these IHC markers in a clinical setting. Research question: Are the new proposed IHC markers clinically useful? Methods: In total, 244 patients with meningiomas with tissue in TMAs were included and the IHC markers S100B, SCGN, ACADL and MCM2 were analyzed. Two sets of analyses were performed; the first included all samples with any staining considered positive, the second only samples with >10% immunopositivity. PFS and OS were analyzed in correlation to immunopositivity in the second analysis set. Results: In the first set of analyses only 26.2% of samples could be to allocate to one group. No further analyses were performed with this selection. In the second set of analyses 52.0% could be allocated to a group. There was an enrichment of WHO grade 2 and 3 tumors in MG3 and MG4 as compared to MG1 (24.1% and 25.7% vs. 12.1%). Both the molecular group (p = 0.032) and WHO grade (p = 0.005) had significant impact on PFS, but only WHO grade predicted OS (p = 0.033). Conclusion: We studied the proposed new method of classifying meningiomas into groups MG1, MG2, MG3 and MG4 using IHC markers, but found difficulties applying the classification system in our material mainly due to lack of exclusivity of markers. Thus, in its present form the classification method lacks clinical applicability. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 2772-5294 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: http://www.sciencedirect.com/science/article/pii/S2772529422008529; https://doaj.org/toc/2772-5294 – Name: DOI Label: DOI Group: ID Data: 10.1016/j.bas.2022.101711 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/3526948f62164cc3891252fd2ef9d639" linkWindow="_blank">https://doaj.org/article/3526948f62164cc3891252fd2ef9d639</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.3526948f62164cc3891252fd2ef9d639 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.3526948f62164cc3891252fd2ef9d639 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.bas.2022.101711 Languages: – Text: English Subjects: – SubjectFull: Meningioma Type: general – SubjectFull: Molecular marker Type: general – SubjectFull: Recurrence Type: general – SubjectFull: Immunohistochemistry Type: general – SubjectFull: Neurology. Diseases of the nervous system Type: general – SubjectFull: RC346-429 Type: general Titles: – TitleFull: Meningioma classification by immunohistochemistry: A replicability study Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Olivia Näslund – PersonEntity: Name: NameFull: Anna Lipatnikova – PersonEntity: Name: NameFull: Anna Dénes – PersonEntity: Name: NameFull: Cecilia Lindskog – PersonEntity: Name: NameFull: Thomas Olsson Bontell – PersonEntity: Name: NameFull: Anja Smits – PersonEntity: Name: NameFull: Asgeir S. Jakola – PersonEntity: Name: NameFull: Alba Corell IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 27725294 Numbering: – Type: volume Value: 3 – Type: issue Value: 101711- Titles: – TitleFull: Brain and Spine Type: main |
ResultId | 1 |